Ignite Creation Date:
2024-05-06 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 2:27 PM
Study NCT ID:
NCT05276713
Status:
UNKNOWN
Last Update Posted:
2022-03-11
First Post:
2022-03-03
Brief Title:
Outcome of Tucidinostat-Based Therapy in HR Metastatic Breast Cancer Patients Previously Treated With CDK46 Inhibitor
Sponsor:
Beijing 302 Hospital
Organization:
Beijing 302 Hospital
Organization Data
Organization:
Beijing 302 Hospital
Class:
OTHER
Study ID:
Breast-Chi-2022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing 302 Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None